Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 55

Results For "net-profit"

576 News Found

Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr
News | July 28, 2021

Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr

The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.


Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr
News | July 28, 2021

Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr

The company posted net profit of Rs.321 crores for the period ended June 30, 2020.


Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr
News | July 28, 2021

Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr

The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.


Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr
News | July 28, 2021

Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr

The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.


Alembic Pharmaceuticals Q1FY22 net slides to Rs. 164.52 Cr
News | July 27, 2021

Alembic Pharmaceuticals Q1FY22 net slides to Rs. 164.52 Cr

The US business faced price erosion due to increased competition.


Biocon Q1FY22 revenue up 6% at Rs 1,808 Cr
News | July 23, 2021

Biocon Q1FY22 revenue up 6% at Rs 1,808 Cr

Q1 FY22 consolidated revenue grew 6% to Rs. 1,808 crore from Rs. 1,712 crore in Q1 FY21. Q1 FY22 Net Profit was Rs. 84 crore (vs. Rs. 149 crore in Q1 FY21).


Gland Pharma Q1FY22 consolidated PAT rises to Rs. 350.65 Cr
News | July 22, 2021

Gland Pharma Q1FY22 consolidated PAT rises to Rs. 350.65 Cr

The company reported total income of Rs.1215.73 crores during the period ended June 30, 2021.


Phyto Chem India posts loss of Rs. 18.57 lakhs in Q4
News | July 04, 2021

Phyto Chem India posts loss of Rs. 18.57 lakhs in Q4

The company has reported total income of Rs.45.29 crores during the 12 months period ended March 31, 2021


Kwality Pharmaceuticals Q4FY21 consolidated PAT higher at Rs. 8.14 Cr
News | July 04, 2021

Kwality Pharmaceuticals Q4FY21 consolidated PAT higher at Rs. 8.14 Cr

The company reported total income of Rs.263.60 crores during the 12 months period ended March 31, 2021


Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr
News | July 02, 2021

Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr

The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021